Symptoms and Endoscopic Results in Consideration of Pretreatment

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00612404

Enrollment

16255

Registered

2008-02-11

Start date

2005-09-30

Completion date

Unknown

Last updated

2008-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Diseases

Keywords

gastrointestinal disorder, endoscopy, patient with gastrointestinal disorders for whom an endoscopy is performed and who is treated with esomeprazole afterwards.

Brief summary

Under daily routine conditions and without any intervention by the sponsor regarding the selection of subjects, diagnostic procedures, therapeutic decisions (medicinal and non- medicinal therapy, dose, duration, etc.), routine assessments, the participating physicians (i.e. gastroenterologists) are asked to document relevant data in patients with gastrointestinal disorders.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* patients with gastrointestinal disorders who need an endoscopy.

Exclusion criteria

* limitiations; possible risks; warnings; contraindications mentioned in the SPC.

Design outcomes

Primary

Measure	Time frame
to gain insight into the relationship between subjective gastrointestinal symptoms and findings of a laryngopharyngeal-esophagogastric endoscopy with respect to the medicinal pre-therapy;	—

Secondary

Measure	Time frame
to gain insight into the currently used treatment strategies with esomeprazole depending on endoscopic findings.	—

Outcome results